Prevention | Page 7 | Alzheimer's Prevention Registry

You are here

Prevention

Alzheimer’s Prevention Registry Reaches Significant Milestone of 200,000 Enrollees

The Alzheimer’s Prevention Registry (APR) enrolled its 200,000th volunteer interested in participating in studies aimed at preventing the disease, a significant milestone in the fight against Alzheimer’s.

Ask the Expert: Weight Gain and Memory

Dear Dr. Morris, My extended family hosts many gatherings this time of year, beginning with a huge Thanksgiving celebration. We’re not only a big group, but many of us seem to be growing bigger around our waistlines in recent years. 
When I’ve suggested dieting as a family, they listen and then grab another soda or more chips. I’m hoping the latest information linking obesity and Alzheimer’s disease may motivate them to change. What can I do to encourage my family to embrace health and still have happy holiday celebrations

 

Alzheimer's is a young(er) person's disease -- so get to work

A discussion about the importance of Alzheimer’s research funding, especially since the disease has been shown to develop 20 to 30 years before one first starts noticing lapses in memory.

Collaboration for Alzheimer’s Prevention: An Initiative to Advance Alzheimer’s Disease Research

A convergent initiative to improve Alzheimer disease prevention research coined as Collaboration for Alzheimer's Prevention has been created. The trial findings will allow preclinical AD research to progress in a more effective way, allowing the swifter development of AD prevention therapies

Family with History of Rare Alzheimer's Gene Hopes for a Cure

Marty Reiswig's family has history of a rare, inherited form of early-onset Alzheimer's disease. The 36-year-old could undergo tests to learn if he will also get the disease, but he has chosen not to.

Drug Shows Promise in Reducing Agitation Due to Alzheimer’s

Drug Shows Promise in Reducing Agitation Due to Alzheimer’s.jpg

A new study suggests that a drug already on the market may help people with Alzheimer's disease-related agitation. The drug, called AVP923, has approval from the Food and Drug Administration (FDA) to treat a disorder called pseudobulbar affect. The study, led by Cleveland Clinic neurologist Jeffrey L. Cummings, MD, suggests that the drug also may help manage agitation in patients with Alzheimer's.

Why Prevention Research

The Alzheimer’s Prevention Registry focuses its work on supporting Alzheimer’s prevention research. These studies offer a unique opportunity to find ways to stop Alzheimer’s disease before it starts.

We'll never give up on pursuing treatments for those with symptoms, and we work with researchers who pursue a mix of strategies in their approach to the disease. A new wave of prevention studies is launching now, with many more following in the years to come.

Excess Weight at Age 50 Tied to Earlier Alzheimer’s Onset

Previous studies have shown that being overweight at midlife is associated with an increased risk of developing Alzheimer's. Now researchers have found that it also predicts occurrence at a younger age.

Read More >>

Dementia and the Three-Second Rate

Every three seconds, another person is diagnosed with dementia somewhere in the world. It's statistics like this that reinforce the importance of research to prevent dementia or to delay the onset of the disease. In September's Alzheimer's Prevention Bulletin, we explore dementia's toll today and its predicted impact on future generations.